Evidence map›Paper›PMID 24422023›Full record

ArticleJournal of oral & maxillofacial research2013

Effect of mandibular advancement device therapy on the signs and symptoms of temporomandibular disorders.

Ritva Näpänkangas, Antti Raunio, Kirsi Sipilä, Aune Raustia

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oral & maxillofacial research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Assessment of the Sensitivity, Specificity, and Accuracy of Thermography in Identifying Patients with TMD.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Trial
  3. Article
  4. Article
  5. Review
  6. Assessment of oral appliance for obstructive sleep apnea patients.Clinical and experimental dental research · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ritva NäpänkangasDepartment of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Oulu Finland. ; Department of Oral and Maxillofacial Surgery, Oulu University Hospital Finland.
Antti RaunioDepartment of Oral and Maxillofacial Surgery, Oulu University Hospital Finland. ; Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Oulu Finland.
Kirsi SipiläDepartment of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Oulu Finland. ; Institute of Dentistry, University of Eastern Finland, Finland and Oral and Maxillofacial Department, Kuopio University Hospital Finland.
Aune RaustiaDepartment of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Oulu Finland. ; Department of Oral and Maxillofacial Surgery, Oulu University Hospital Finland.
University of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMandibular advancement device therapy is effectively used in the treatment of obstructive sleep apnea, but also several side effects in the masticatory system have been reported. The aim of this study was to evaluate the subjective symptoms and clinical signs of temporomandibular disorders connected to mandibular advancement device therapy. MATERIAL AND

methodsThe material consisted of 15 patients (9 men and 6 women, mean age 51.1 years, range 21 to 70 years) diagnosed with obstructive sleep apnea (OSA). Subjective symptoms and clinical temporomandibular disorders (TMD) signs were recorded at the beginning of the treatment (baseline) and at 1-month, 3-month, 6-month and 24-month follow-ups. The degree of TMD was assessed using the anamnestic (Ai) and the clinical dysfunction index (Di) of Helkimo. For assessing the effect of TMD the patients were divided in discontinuing and continuing groups.

resultsAccording to Ai and Di, the severity of TMD remained unchanged during the follow-up in most of the patients. Temporomandibular joint (TMJ) crepitation was found more frequently in discontinuing patients at all follow-ups. The difference was statistically significant (P < 0.05) at the six-month follow-up. Masticatory muscle pain during palpation was a frequent clinical sign at the baseline and during the follow-up period but the difference between discontinuing and continuing patients was not significant.

conclusionsIt seems that signs and symptoms of temporomandibular disorders do not necessarily increase during long-term mandibular advancement device therapy. However, it seems that patients with clinically assessed temporomandibular joint crepitation may discontinue their mandibular advancement device therapy due to temporomandibular disorders.

Indexed as

follow-up studies.mandibular advancementmedical devicesleep apneatemporomandibular disorders

Identifiers

PMID24422023
PMCPMC3886094
OpenAlexW1964330250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.